Hematology


Arsenic Sulfide in Acute Promyelocytic Leukemia (APL) 5-year D

5-year DFSDFS:disease-free survival of Arsenic Sulfide in acute promyelocytic leukemia (APL) is about 95%. This arsenic sulfide medicine is the patent of our hospital.


Stay in Touch
©2017 Lu Daopei hospital-22 Tongji South Rd, Yizhuang Ecomonic and Technological Development Zone, Daxing District, Beijing, China. All rights reserved.
冀ICP备18002416号-1